Dear Ms. Jyoti J. Sardesai Director FDA, Food & Drugs Administration Bambolim - Opp Holy Cross Goa
Date: 2..2.2019 Copy to : 1. Director of National Institute of Oceanography Dona Paula -Goa 2, Dr. Kalpana Chiodankar, NIO Medical Officer 3. Dr. Ivone Fernandes, NIO Medical Officer 4. Chief Secretary Goa State 5. Personal File Dear Madam, With reference to your reply letter FDA/No. 31/DFDA/37B/2018-19 dated nil, in response to my complaint dated 21.6.2018 regarding the faulty supply of medicine Renerve Plus which I have sent the defective capsule/strip immediately to your office for investigation/analysis and reporting. I have received your reply by email today after the period of six months on testing done at your laboratory at Bambolim. I understand that your inspection was carried out at the M/s Wellness pharmacy, Panjim where I purchased these strips. When I have questioned their pharmacists they told me that they only dispense medicine supplied by distributors but they do not manufacture them and they are not responsible. The leakage was clearly visible on the strip/capsule and the same sample is delivered soon to your laboratory for analysis. I have received a complete report from you yesterday by email citing all the analysis performed by your analyst. I appreciate your reporting done on this drug. My observation is that whether this test is done on the sample given by me or from a fresh new sample received from the pharmacy? Kindly clear my doubt because it is not mentioned in your report. I have no problem with this pharmacy because I consider they dispensation of medicine and staff are of high standards but this kind of medicine which I feel is being transported at higher climate condition could develop such leakages.. Since this supply I assume is coming all the way from Daman state, such leakage could lead to all sorts of illness even cancer to the patient if this kind of medicines is consumed. Hope you will understand our difficulties and request to keep a vigil or check for such distribution of medicines in our pharmacies in Goa. Awaiting your reply soon and please specify whether these tests for all the ingredients are done at your laboratory at Bambolim or outside of your lab. Kind Regards Yours faithfully Stephen Dias Retd Scientist of NIO Dona Paula C-22/113 Bay View -Dona Paula 403004 Mob 9422443110 On Thu, 31 Jan 2019 at 14:22, FOOD AND DRUGS ADMN GOA <off-dfda....@nic.in> wrote: > Sir, > > Kindly find this Directorate's letter on the subject cited above. > > > Regards, > Directorate of Food & Drugs Admn, Goa > > > On 06/21/18 09:29 PM, *Stephen Dias * <steve.dia...@gmail.com> wrote: > > This complaint may be routed through NIO Dispensary committee for follow > up with Wellness as this is a serious issue which may affect patients if > these capsules are consumed. > Directorate of Food and Drug Controller ( FDA) may please investigate for > further compliance. > > Stephen Dias > Mob 9422443110 > >